BioTech Health XMay 23, 2023 Biotech News2seventy bio Secure $170 Million Extending Cash Runway Into 2025 3 minute read 2seventy bio (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced that it has agreed to sell… 0 Shares 0 0 0 0 0 0 0